CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
Abstract Hepatocellular carcinoma (HCC) is a common malignancy in human. CD44 is a transmembrane glycoprotein which is frequently overexpressed in cancer of various origins. The function and mechanism of CD44 in HCC remains elusive. In this study, we reported that CD44 was overexpressed in HCC to pr...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a0f2cfa14d3a42d0b8233f2d622ff2b1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a0f2cfa14d3a42d0b8233f2d622ff2b1 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a0f2cfa14d3a42d0b8233f2d622ff2b12021-11-21T12:07:59ZCD44 promotes hepatocellular carcinoma progression via upregulation of YAP10.1186/s40164-021-00247-w2162-3619https://doaj.org/article/a0f2cfa14d3a42d0b8233f2d622ff2b12021-11-01T00:00:00Zhttps://doi.org/10.1186/s40164-021-00247-whttps://doaj.org/toc/2162-3619Abstract Hepatocellular carcinoma (HCC) is a common malignancy in human. CD44 is a transmembrane glycoprotein which is frequently overexpressed in cancer of various origins. The function and mechanism of CD44 in HCC remains elusive. In this study, we reported that CD44 was overexpressed in HCC to promote the proliferation and migration of HCC cells via oncogenic YAP, which is the key downstream regulator in Hippo pathway. These findings suggest that CD44-YAP is a probable important axis in pathogenesis of HCC, providing an insight in to HCC pathogenesis as well as potential targets for the intervention of HCC.Jun ZhangXilin HeYajie WanHonghong ZhangTao TangMeng ZhangShiyi YuWeiyong ZhaoLiming ChenBMCarticleHepatocellular carcinomaCD44YAPDiseases of the blood and blood-forming organsRC633-647.5Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENExperimental Hematology & Oncology, Vol 10, Iss 1, Pp 1-4 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Hepatocellular carcinoma CD44 YAP Diseases of the blood and blood-forming organs RC633-647.5 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Hepatocellular carcinoma CD44 YAP Diseases of the blood and blood-forming organs RC633-647.5 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Jun Zhang Xilin He Yajie Wan Honghong Zhang Tao Tang Meng Zhang Shiyi Yu Weiyong Zhao Liming Chen CD44 promotes hepatocellular carcinoma progression via upregulation of YAP |
description |
Abstract Hepatocellular carcinoma (HCC) is a common malignancy in human. CD44 is a transmembrane glycoprotein which is frequently overexpressed in cancer of various origins. The function and mechanism of CD44 in HCC remains elusive. In this study, we reported that CD44 was overexpressed in HCC to promote the proliferation and migration of HCC cells via oncogenic YAP, which is the key downstream regulator in Hippo pathway. These findings suggest that CD44-YAP is a probable important axis in pathogenesis of HCC, providing an insight in to HCC pathogenesis as well as potential targets for the intervention of HCC. |
format |
article |
author |
Jun Zhang Xilin He Yajie Wan Honghong Zhang Tao Tang Meng Zhang Shiyi Yu Weiyong Zhao Liming Chen |
author_facet |
Jun Zhang Xilin He Yajie Wan Honghong Zhang Tao Tang Meng Zhang Shiyi Yu Weiyong Zhao Liming Chen |
author_sort |
Jun Zhang |
title |
CD44 promotes hepatocellular carcinoma progression via upregulation of YAP |
title_short |
CD44 promotes hepatocellular carcinoma progression via upregulation of YAP |
title_full |
CD44 promotes hepatocellular carcinoma progression via upregulation of YAP |
title_fullStr |
CD44 promotes hepatocellular carcinoma progression via upregulation of YAP |
title_full_unstemmed |
CD44 promotes hepatocellular carcinoma progression via upregulation of YAP |
title_sort |
cd44 promotes hepatocellular carcinoma progression via upregulation of yap |
publisher |
BMC |
publishDate |
2021 |
url |
https://doaj.org/article/a0f2cfa14d3a42d0b8233f2d622ff2b1 |
work_keys_str_mv |
AT junzhang cd44promoteshepatocellularcarcinomaprogressionviaupregulationofyap AT xilinhe cd44promoteshepatocellularcarcinomaprogressionviaupregulationofyap AT yajiewan cd44promoteshepatocellularcarcinomaprogressionviaupregulationofyap AT honghongzhang cd44promoteshepatocellularcarcinomaprogressionviaupregulationofyap AT taotang cd44promoteshepatocellularcarcinomaprogressionviaupregulationofyap AT mengzhang cd44promoteshepatocellularcarcinomaprogressionviaupregulationofyap AT shiyiyu cd44promoteshepatocellularcarcinomaprogressionviaupregulationofyap AT weiyongzhao cd44promoteshepatocellularcarcinomaprogressionviaupregulationofyap AT limingchen cd44promoteshepatocellularcarcinomaprogressionviaupregulationofyap |
_version_ |
1718419202961833984 |